К содержанию
Dr. Tara EinullaevaMedical oncologist

Treatment 7 min

Lung metastases: when drugs are enough and when surgery, radiotherapy or ablation are needed

Lung metastases from colorectal, kidney and breast cancer, melanoma and sarcoma: how to tell them from lung cancer, the role of systemic therapy, metastasectomy, stereotactic radiotherapy and ablation.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 31 October 2026

The lungs are one of the commonest places where tumours of other organs spread: colorectal, kidney and breast cancer, melanoma, sarcomas, head and neck tumours, germ cell tumours. Finding lung metastases on CT is hard news, but from it to a treatment plan there is a clear path. In some cases the disease can be controlled for a long time, and with single lesions complete removal is sometimes achieved.

In this article I explain how to make sure these are metastases, what treatment usually starts with, when surgery, radiotherapy or ablation are discussed and what to watch for.

Metastasis or something else

A new lung nodule in a person with a cancer diagnosis is not always a metastasis. It may be:

  • a metastasis (more often several round lesions of different sizes);
  • primary lung cancer (especially in smokers and ex-smokers), which is treated by different rules: mutations in lung cancer;
  • inflammation or scar;
  • a benign lesion.

What helps to clarify:

  • CT of the chest: number, size, shape, change compared with previous scans;
  • PET-CT, especially for lesions over 1 cm (what PET-CT shows);
  • watching over time at 1–3 months for small lesions;
  • biopsy (percutaneous under CT guidance or bronchoscopic) if the result will change treatment: for example when a single nodule has appeared several years after treatment of another tumour.

If pathology of the metastasis is available, it is important to compare it with the primary tumour: metastases without a known primary.

Symptoms

Many metastases cause no symptoms and are found on a follow-up CT. Sometimes there are:

New breathlessness or cough in a person with a tumour needs investigation. If you are unsure how urgent it is, use the symptom check.

The basis of treatment: systemic therapy

For most patients with lung metastases the basis of treatment is drug therapy chosen for the primary tumour. A metastasis behaves like the tumour it came from, so the regimens are the same:

Primary tumour Typical approaches
Colorectal cancer Chemotherapy, targeted drugs, immunotherapy in MSI-H (colorectal cancer treatment, MSI and dMMR)
Breast cancer Hormonal, anti-HER2, chemotherapy, others (breast cancer)
Kidney cancer Immunotherapy and targeted drugs (kidney cancer)
Melanoma Immunotherapy, targeted therapy with BRAF (melanoma treatment, case)
Sarcomas Chemotherapy, sometimes surgery (soft tissue sarcoma)
Bladder cancer Platinum chemotherapy, immunotherapy (bladder cancer)
Germ cell tumours Platinum chemotherapy with high chances of cure (testicular cancer)

More on principles: targeted therapy, immunotherapy, chemotherapy regimens.

When local treatment is discussed

Sometimes there are few lung metastases (one to five lesions), and there is no disease outside the lungs or it is well controlled. This state is called oligometastatic (oligometastases). Here local methods are added to drugs, aiming to remove visible disease and allow longer treatment without a change, and in some cases (for example in sarcomas, colorectal and kidney cancer, germ cell tumours) to achieve long remission.

The criteria under which this is usually discussed:

  • the primary tumour has been removed or is controlled;
  • metastases are few and can be removed completely;
  • there are no uncontrolled lesions in other organs;
  • lung function and general condition allow treatment;
  • the lesions grow slowly: slow growth is considered a favourable sign.

Surgical removal (metastasectomy)

Metastases are removed with minimally invasive (thoracoscopic) or open surgery. The surgeon tries to preserve as much healthy tissue as possible. Metastasectomy has the longest experience in sarcomas, kidney cancer, germ cell tumours and selected cases of colorectal cancer. Its benefit has been studied differently in different situations: for example, evidence in colorectal cancer is debated, so the decision should be individual, at a tumour board.

Stereotactic radiotherapy (SBRT)

Irradiation of a lesion with a high dose over 1–5 sessions. It suits small lesions (usually up to 5 cm) and people who cannot tolerate surgery. It often controls the lesion well; side effects are usually moderate (fatigue, cough, sometimes lung tissue inflammation lasting months).

Ablation

Thermal destruction of a lesion with a needle under CT guidance (radiofrequency, microwave, cryoablation). It suits small peripheral metastases. Risks: pneumothorax (air collection), bleeding.

Which method to choose depends on the size and location of the lesion, the number of lesions and the centre's experience. There is no universal answer, and it is sensible to discuss the options with specialists of each field.

What to do when only one or two lesions grow

If during treatment most lesions have shrunk or are stable and one or two are growing (oligoprogression), it is sometimes better to remove the growing lesions locally (with radiotherapy or ablation) and continue the same therapy than to change it. This decision is made at a tumour board: progression on treatment.

Lymphangitis and many small lesions

When the lungs contain many small lesions or tumour cells spread along lymphatic vessels (lymphangitis), local methods are not used and treatment rests on systemic therapy. Breathlessness is then common, and it is important to discuss supportive care in time, including oxygen and drugs that ease breathlessness: palliative chemotherapy.

Complications and supportive care

Follow-up

The effect is assessed by CT of the chest every 2–3 months at the start of treatment and less often later (RECIST). With systemic therapy, other manifestations of disease are assessed alongside CT.

What to ask your doctor

  • Are these definitely metastases? Is a biopsy needed?
  • How many lesions and what size?
  • Is there disease outside the lungs?
  • Which systemic treatment suits me?
  • Can it be supplemented with surgery, radiotherapy or ablation?
  • Which centre performs such procedures regularly?
  • How often should CT be done?
  • What do we do if one lesion grows?

When to seek urgent help

  • sudden shortness of breath or lack of air at rest;
  • coughing up blood;
  • severe chest pain;
  • temperature of 38 °C or above, cough with phlegm;
  • swelling and pain in one leg (see thrombosis in cancer);
  • blue lips, confusion.

If you cannot get air, call an ambulance.

Can I get a second opinion

Yes, and in lung metastases it often moves treatment into another category: from "palliative only" to "a chance of control or even cure". Reasons: metastases are few but only drugs are offered without discussing local methods; surgery is offered without discussing radiotherapy or ablation; no biopsy was done for an unclear nodule; one lesion has grown. Prepare the CT with discs, pathology of the primary tumour and summaries: documents for a second opinion, preparing for a consultation. If you need a review, book a consultation: I study the documents in advance and send a written summary.

Sources

  1. Metastatic Cancer: When Cancer Spreads — National Cancer Institute
  2. ESMO Clinical Practice Guidelines — ESMO
  3. Practical guidelines for drug treatment of malignant tumours — RUSSCO (Russian Society of Clinical Oncology)
  4. Clinical guidelines (Russia) — Russian Ministry of Health

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.